Introduction
============

The structural and functional integrity of the retina depends on a regular oxygen supply. Being one of the most metabolically active tissues, retina consumes oxygen more rapidly than other tissues ([@b44-co-2-879]) such as the brain ([@b7-co-2-879]; [@b5-co-2-879]). The presence of a dual circulation ([@b168-co-2-879]) makes retinal oxygenation unique. The photoreceptors and the greater portion of the outer plexiform layer receive nourishment from the choriocapillaris indirectly whereas the inner retinal layers are supplied by the superficial and deep capillary plexuses formed by branches of the central artery of the retina. Inner layers of the retina are known to show highest sensitivity to hypoxic challenges ([@b100-co-2-879]), whereas the outer retina is more resistant to a hypoxic stress ([@b206-co-2-879]).

Retinal hypoxia occurs in ocular conditions such as central retinal artery occlusion and ischemic central retinal vein thrombosis. Hypoxia is also implicated in the development of glaucoma ([@b65-co-2-879]; [@b205-co-2-879]; [@b43-co-2-879]; [@b169-co-2-879]; [@b46-co-2-879]; [@b203-co-2-879]), diabetes ([@b133-co-2-879]), and is thought to underlie many of the sight-threatening complications of diabetic eye disease including retinal and optic nerve head neovascularization. Systemic causes of retinal hypoxia include the cardiovascular effects of chronic obstructive airways disease, the ocular ischemic syndrome associated with arterial obstructive conditions such as carotid artery stenosis ([@b26-co-2-879]) and Takayasu's arteritis ([@b189-co-2-879]), hyperviscosity syndromes ([@b9-co-2-879]) or following trauma (Purtscher's retinopathy; [@b176-co-2-879]; Buckley and James 1997). Retinal hypoxia associated with the above conditions is a common cause of visual impairment and blindness ([@b168-co-2-879]). Retinal ganglion cells (RGCs) have been reported to be particularly sensitive to acute, transient, and mild systemic hypoxic stress ([@b115-co-2-879]). Loss of RGCs occurs in many ophthalmic conditions such as glaucoma and diabetes ([@b198-co-2-879]; [@b2-co-2-879]), hypoxia being implicated in such a loss ([@b214-co-2-879]; [@b203-co-2-879]; [@b38-co-2-879]). This review details some of the molecular and cellular mechanisms which may be involved in RGC death in ocular conditions associated with hypoxia-ischemia. A better understanding of the mechanisms causing hypoxic damage to RGCs may aid the development of therapies aimed at reducing blindness from retinal hypoxic-ischemic visual loss.

A number of systemic and cellular responses such as glycolysis, angiogenesis, vasodilation, and erythropoiesis enable the organisms to respond to hypoxia ([@b83-co-2-879]). The neural tissue is capable of inducing protective mechanisms under hypoxic-ischemic conditions ([@b118-co-2-879]) which are induced within minutes and are of putative importance for limiting the damage. However, these protective mechanisms are lost within hours of the hypoxic-ischemic insult ([@b172-co-2-879]) following which cell death and tissue damage occur. Transcriptional activator hypoxia-inducible factor-1α (HIF-1α) is a master regulator of cellular O~2~ homeostasis ([@b97-co-2-879]). Hypoxia is known to induce HIF-1α and its target genes ([@b14-co-2-879]) such as vascular endothelial growth factor (VEGF) and nitric oxide synthase (NOS) in many tissues. Overproduction of these factors has been implicated in neuronal death in hypoxic-ischemic conditions. In addition, enhanced extracellular accumulation of glutamate and inflammatory cytokines damage the neurons. Upregulated expression of HIF-1α, VEGF, and various isoforms of NOS has been reported in the retina following hypoxic injury ([@b113-co-2-879]) and in the glaucomatous retina ([@b203-co-2-879]).

Retinal ganglion cell death in hypoxia ischemia
===============================================

RGC death has been reported to occur in many experimental studies using different methods to induce retinal ischemia ([@b3-co-2-879]; [@b72-co-2-879]; [@b124-co-2-879]; [@b213-co-2-879]; [@b41-co-2-879]). Neuronal degeneration resulting from retinal hypoxia-ischemia, caused by oxygen and substrate deprivation, may be mediated by free oxygen radicals ([@b16-co-2-879]; [@b158-co-2-879]; [@b200-co-2-879]), glutamate excitotoxicity ([@b136-co-2-879]; [@b168-co-2-879]; [@b113-co-2-879]), inflammation (Hayashi et al 1996) as well as disruption of the blood retinal barrier ([@b122-co-2-879]; [@b114-co-2-879]).

Based on morphological, histochemical, and biochemical criteria, cell death has been classified as apoptotic or necrotic in hypoxic-ischemic conditions ([@b148-co-2-879]; [@b37-co-2-879], [@b36-co-2-879]; [@b42-co-2-879]; [@b139-co-2-879]; [@b220-co-2-879]; [@b141-co-2-879]; [@b11-co-2-879]; [@b175-co-2-879]; [@b181-co-2-879]; [@b160-co-2-879]). In necrotic death, swelling of cell body, disruption of plasma membrane, and irregularly scattered condensation of nuclear chromatin occur ([@b57-co-2-879]; [@b76-co-2-879]; [@b193-co-2-879]). In apoptosis, on the other hand, nuclear condensation and contraction occurs early with the membrane and organelles remaining intact until the final stages. Similar necrotic ([@b28-co-2-879]; [@b105-co-2-879]) and apoptotic changes in RGCs have been observed in experimental hypoxic-ischemic conditions ([@b28-co-2-879]; [@b106-co-2-879], [@b105-co-2-879]) as well as in elevated intraocular pressure ([@b67-co-2-879]; [@b177-co-2-879]) and glaucoma (Kerrigan et al 1996) where ischemia is involved in retinal damage directly or indirectly.

Ischemia is known to induce several apoptosis-regulatory genes in cells. Upregulated expression of Bax, a bcl-2 homolog that effects apoptosis in neurons destined to die, after global ischemia ([@b121-co-2-879]; Chen et al 1996) and expression of antiapoptotic gene *bcl-2* in neurons that survive ischemia ([@b191-co-2-879]; [@b39-co-2-879]) has been reported suggesting that endogenously induced apoptosis-regulatory genes may play a role in determining the fate of ischemic neurons. Caspases play a key role in cell death by apoptosis ([@b99-co-2-879]). Among the caspases, caspase-3 is activated by many cell death signals and cleaves a variety of important cellular proteins ([@b101-co-2-879]; [@b161-co-2-879]). Caspase-3-like protease activation is likely to be relevant in neuronal apoptosis in ischemic injury ([@b63-co-2-879]; [@b161-co-2-879]). Caspase-2 and -3 ([@b123-co-2-879]; [@b125-co-2-879]) and Bax ([@b110-co-2-879]) have been reported to be involved in retinal cell loss after ischemic insult.

Hypoxia-ischemia, retinal edema, and vascular endothelial growth factor
=======================================================================

Hypoxia-ischemia underlies various blinding ocular conditions such as diabetic retinopathy and may play a role in the wet form of age-related macular degeneration and in the visual loss from retinal detachment ([@b209-co-2-879]; [@b218-co-2-879]; [@b143-co-2-879]; [@b25-co-2-879]; [@b52-co-2-879]; [@b98-co-2-879]). It is associated with fluid accumulation in the extracellular spaces (vasogenic edema) or intracellulary (cytotoxic edema) in the neural retina ([@b218-co-2-879]; [@b143-co-2-879]). The extracellular spaces in the inner retina consist of the narrow clefts between the tightly packed cellular elements ([@b80-co-2-879]). Fluid leaking out from damaged capillaries in the inner retina accumulates in the extracellular spaces displacing the retinal cellular elements and disrupting the normal anatomy of the neuronal connections ([@b81-co-2-879]). Factors implicated in pathogenesis of macular edema are retinal ischemia, oxidative stress, and inflammation ([@b24-co-2-879]; [@b75-co-2-879]; [@b210-co-2-879]; [@b155-co-2-879]). Increased permeability of blood-retinal barrier (BRB) resulting in fluid accumulation has been reported to contribute to retinal neuronal degeneration by compression ([@b50-co-2-879]; [@b8-co-2-879]; [@b143-co-2-879]; [@b180-co-2-879]). Excess production of VEGF, nitric oxide (NO) and aquaporin-4 in hypoxic-ischemic insults causes dysfunction of the BRB in the inner retina resulting in serum leakage into the retinal tissues ([@b143-co-2-879]; [@b114-co-2-879]) and retinal edema ([@b81-co-2-879]). In addition to an increase in vascular permeability, hypoxia has also been correlated with endothelial cell death, leukocyte plugging of vessels, and microaneurysms ([@b133-co-2-879]).

VEGF, also known as vascular permeability factor (Senger et al 1983), is a key player of angiogenesis in health and disease ([@b61-co-2-879]; [@b33-co-2-879]). VEGF binds to two tyrosine kinase receptors, VEGFR-1 or fms-like tyrosine kinase Flt-1 and VEGFR-2 or fetal liver kinase receptor Flk-1 to exert its actions ([@b55-co-2-879]; [@b178-co-2-879]; [@b163-co-2-879]; Shibuya 2001). VEGF is inducible by hypoxia-ischemia *in vitro* and *in vivo* and has been suggested as a likely candidate for the development of vasogenic brain edema ([@b187-co-2-879]). A 3--12-fold increase in VEGF gene expression has been reported in hypoxia ([@b94-co-2-879]; [@b129-co-2-879]; [@b196-co-2-879]).

Increased expression of VEGF has been reported in hypoxic brains ([@b187-co-2-879]; [@b113-co-2-879]), and astrocytes were identified as the cells expressing VEGF ([@b113-co-2-879]). Upregulation of endogenous VEGF in astrocytes in hypoxia-ischemia is believed to interact with receptors for VEGF on the vessels and contribute to the disruption of blood-brain barrier (BBB) resulting in vascular leakage ([@b221-co-2-879], [@b222-co-2-879]). Inhibition of VEGF is known to reduce the BBB permeability ([@b221-co-2-879]). Similar to the brain, increased production of VEGF and enhanced permeability of BRB was recently reported in the hypoxic retina and inhibition of VEGF production with melatonin reduced BRB permeability ([@b113-co-2-879], [@b114-co-2-879]).

In addition to its role in increasing vascular permeability, VEGF has also been described as an inflammatory mediator which contributes to inflammatory responses observed in cerebral ischemia ([@b49-co-2-879]). The disruption of BBB by VEGF allows contact of normally sequestered central nervous system antigens with blood-borne immune mediators altering the immune privileged status of the brain ([@b173-co-2-879]). VEGF enhances the adhesion of leukocytes to vascular walls and increases intercellular cell adhesion molecule-1(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression in the brain and retina ([@b150-co-2-879]; [@b137-co-2-879]; [@b151-co-2-879]). Overexposure of normal neural tissue to VEGF has been shown to enhance ICAM-1 and major histocompatibility complex class I and II expression (Proescholdt et al 2004). Many changes induced by diabetes such as ICAM-1 up-regulation, leukocyte adhesion and increased vascular permeability in the retina ([@b159-co-2-879]; [@b6-co-2-879]) have been reported to occur in nondiabetic retinas with intravitreous VEGF injections ([@b208-co-2-879]; [@b137-co-2-879]) supporting the role of VEGF in inflammation. Suppression of inflammation in retina after VEGF inhibition has been reported ([@b108-co-2-879]).

Intracellular edema has been reported to occur in ischemia through damage to the cell membrane ionic channels ([@b143-co-2-879]). Neuronal and/or glial swelling has been considered as a component of retinal edema. The neuronal cells have been reported to become edematous during ischemia and degenerate eventually in the post-ischemic period ([@b104-co-2-879]).

Hypoxia-ischemia and nitric oxide
=================================

NO is known to play an important role in the pathogenesis of neuronal injury during hypoxia-ischemia. NO is synthesized by the enzyme NOS from L-arginine. NOS exists in three isoforms: neuronal (nNOS) and endothelial (eNOS) which are constitutively expressed and inducible (iNOS). The activities of nNOS and eNOS are stimulated by increases in intracellular calcium whereas iNOS is calcium-independent, and NO generated from this isoform is known to mediate immune functions. Enhanced nNOS, eNOS, and iNOS expression has been reported in the retina in response to hypoxia ([@b113-co-2-879]).

NO has been described to have neuroprotective and neurotoxic roles (Iadeacola 1997). NO produced by the eNOS isoform is a protective response as it maintains retinal perfusion in hypoxic-ischemic conditions ([@b207-co-2-879]). Vasodilation occurring after hypoxic-ischemic episodes is mediated by eNOS ([@b19-co-2-879]) leading to increased blood flow. Blood vessels in retina showed enhanced expression of eNOS following a hypoxic insult ([@b113-co-2-879]). However, it has been proposed that besides its beneficial effects of producing vasodilatation and increasing the blood flow, eNOS is also involved in VEGF-induced vascular hyperpermeability ([@b66-co-2-879]).

All three types of NOS are produced in the retina in hypoxic-ischemic conditions ([@b113-co-2-879]) and glial cells have been suggested as the major cell types producing them ([@b119-co-2-879]; [@b111-co-2-879]). In addition to glial cells, infiltrating leukocytes may also be an important source of iNOS production. The RGCs were also reported to express iNOS and nNOS in the hypoxic retina ([@b113-co-2-879]). NO production from nNOS and iNOS contributes to cytotoxicity resulting in cell death and axonal damage. Other than generation of free radicals, a number of pathways such as N-methyl-D-aspartate (NMDA)-mediated intracellular Ca^2+^ influx and CREB-mediated transcription of apoptotic proteins such as Bax, Bad, and Bcl-xl are triggered by NO resulting in neuronal death ([@b152-co-2-879], [@b153-co-2-879]; [@b225-co-2-879], [@b226-co-2-879]). Increased expression of Bax but not Bcl-2 in hypoxic cerebral tissue thus increasing the Bax/Bcl-2 ratio in favor of hypoxia-induced apoptosis has been reported ([@b154-co-2-879]). In retinal ischemia, RGCs death has been reported to be due to involvement of iNOS as it has been observed that iNOS-positive leukocytes enter the ganglion cell layer and surround the RGCs and cause their degeneration which could be prevented with an inhibitor of iNOS ([@b162-co-2-879]).

NO induces the proapoptotic cascade in hypoxic neural tissues by increasing phosphorylation of Bcl-2 ([@b154-co-2-879]). NO-mediated inactivation of MAPK phosphatases has been described as a potential mechanism of activation of ERK and JNK which leads to phosphorylation of the antiapoptotic protein Bcl-2 ([@b154-co-2-879]). The anti-apoptotic potential of phosphorylated Bcl-2 is lost due to its inability to heterodimerize with the proapoptotic protein Bax, resulting in Bax-mediated activation of caspases and initiation of apoptosis ([@b195-co-2-879], [@b78-co-2-879]; [@b91-co-2-879]). Other mechanisms by which NO contributes to cytotoxicity may be peroxynitrite-mediated oxidative damage, DNA damage, and energy failure ([@b12-co-2-879]; [@b165-co-2-879]; [@b223-co-2-879]; [@b73-co-2-879]). This observation is supported by recent studies which have suggested that peroxynitrite produced by iNOS is a highly reactive oxidant capable of inducing injury to a number of cell types ([@b130-co-2-879]).

Hypoxia-ischemia and excitotoxicity
===================================

Excitatory amino acids have been reported to play an important role in the development of hypoxic-ischemic retinal injury. Glutamate, the excitatory neurotransmitter in the retina, is released by photoreceptors, bipolar cells and ganglion cells and mediates the transfer of visual signals from the retina to the brain ([@b145-co-2-879]). However, augmented release of glutamate and its accumulation in extracellular spaces in hypoxic-ischemic conditions leading to activation of glutamate receptors has been implicated in hypoxic/ischemic neuronal death ([@b13-co-2-879]; [@b138-co-2-879]). Glutamate neurotoxicity is considered as the underlying problem in retinal neuropathies and neurodegenerative conditions such as glaucoma ([@b59-co-2-879]). Elevation of extracellular glutamate concentration in the retina has been shown to mimic hypoxia induced changes in the electroretinogram ([@b94-co-2-879]). Over-activation of glutamate receptors due to excess glutamate accumulation in the retina can contribute to retinal dysfunction ([@b59-co-2-879]; [@b170-co-2-879]).

Glutamate exerts its action through ionotropic (amino-methyl-propionic-acid \[AMPA\], NMDA, and kainate glutamate receptors) and metabotropic receptors ([@b23-co-2-879]; [@b74-co-2-879]). The metabotropic glutamate receptors (mGluRs) have been grouped into three main classes, group I (mGluR1 and 5), Group II (mGluR2, 3), and Group III (mGluR 4, 6, 7, 8) according to their amino acid sequence, pharmacological properties and transduction mechanisms ([@b45-co-2-879]). RGCs express ionotropic receptors ([@b85-co-2-879]; [@b23-co-2-879]) as well as mGluRs ([@b84-co-2-879]). Glutamate receptor-mediated damage has been reported to occur in glaucoma, central, and branch retinal arterial and retinal vein occlusions resulting in loss of retinal ganglion cells ([@b198-co-2-879]).

Neurotoxic effects of glutamate are reported to occur predominantly through activation of ionotropic glutamate receptors (GluR) (Levy et al 1991). NMDA receptors are highly permeable to Ca^2+^ ([@b140-co-2-879]; [@b90-co-2-879]; [@b182-co-2-879]), their activation resulting in an increase in the intracellular calcium levels ([@b192-co-2-879]; [@b199-co-2-879], [@b197-co-2-879], [@b198-co-2-879]). Ca^2+^ overload has been reported to be a central event in neuronal death during ischemia ([@b166-co-2-879]; [@b186-co-2-879]). Many cellular functions such as regulation of enzymes require calcium. Abnormal higher concentrations of calcium lead to inappropriate activation of enzymes such as proteases, nucleases, and lipases which are harmful to the cellular constituents, generate free radicals as well as cause mitochondrial failure which results in energy depletion and further free radical production ([@b60-co-2-879]).

Depolarization of neuronal membranes due to energy failure results in Ca^2+^ influx through the voltage-dependent Ca^2+^ channels followed by Ca^2+^-dependent glutamate release ([@b112-co-2-879]) which further increases the extracellular accumulation of glutamate. Activation of ionotropic glutamate receptors also results in influx of Na^+^ and Cl^−^ ions, inducing osmotic swelling. Glutamate acting via NMDA receptors activates nNOS ([@b68-co-2-879]) and the production of NO ([@b117-co-2-879]). Expression of ionotropic glutamate receptors (GluR2/3 and NMDA) has been reported to be upregulated in the RGCs in hypoxic-ischemic conditions ([@b113-co-2-879]).

Glutamate has also been reported to induce and exacerbate cell death by activating group I mGluRs ([@b4-co-2-879]; [@b89-co-2-879]). Neuronal excitation and excitotoxicity is thought to be potentiated by Group I mGluRs ([@b30-co-2-879]; [@b171-co-2-879]; [@b31-co-2-879]), possibly through their interaction with NMDA receptors ([@b64-co-2-879]; [@b22-co-2-879]). It has been reported that mGluR5 are coexpressed with, and functionally coupled to, NMDA receptors and that activation of mGluR5 enhances NMDA responses in neurons ([@b102-co-2-879]; [@b10-co-2-879]; [@b184-co-2-879]) contributing to neuronal death ([@b27-co-2-879]).

Glutamate is also known to be involved in the production of inflammatory cytokines such as tumor necrosis factor-α (TNF-α) ([@b54-co-2-879]). Glutamate-induced activation of AMPA and NMDA receptors has been shown to enhance the production of TNF-α ([@b167-co-2-879]; [@b146-co-2-879]) and interleukin-1 β (IL-1β) ([@b77-co-2-879]) significantly. Co-operation between glutamate receptors and inflammatory cytokines may be one of the mechanisms involved in cell damage.

Glutamate toxicity also results in glutathione depletion and oxidative stress ([@b179-co-2-879]). Glutathione is a major cellular antioxidant which protects the cells against oxidative stress ([@b149-co-2-879]; [@b156-co-2-879]; [@b17-co-2-879]). Increase in intracellular reactive oxygen species (ROS) generation in response to glutathione depletion has been reported in several studies ([@b48-co-2-879]; [@b202-co-2-879]).

Removal of excess glutamate from the extracellular space by glutamate transporters is crucial to terminate glutamate excitotoxicty. Glutamate transporters are responsible for the removal of glutamate from the extracellular fluid in the retina ([@b51-co-2-879]). It has been suggested that excess glutamate accumulation in the extracellular spaces may result from a failure of the glutamate transporters, such as GLAST, in the vicinity of RGCs ([@b82-co-2-879]). Glutamate transporters have been described as necessary to prevent excitotoxic retinal damage and to synthesize glutathione and their deficiency has been reported to result in RGC degeneration ([@b82-co-2-879]).

Hypoxia-ischemia and reactive oxygen species
============================================

Hypoxia-ischemia results in perturbation of the cellular pro-oxidant-antioxidant balance by accumulation of ROS, known as oxidative stress, which has been implicated as an important mechanism of cytotoxicity. *In vitro* studies have shown that ROS generation in hypoxic-ischemic conditions in neurons occurs from three sources: mitochondria generating an initial burst of ROS followed by a second phase of ROS generation due to xanthine oxidase activation and a third phase of Ca^2+^-dependent ROS generation ([@b1-co-2-879]).

ROS are known to cause lipid peroxidation, protein oxidation, and DNA oxidation, which contributes to neuro-degeneration ([@b79-co-2-879]; [@b34-co-2-879], [@b35-co-2-879]). ROS can also stimulate ischemic cells to secrete inflammatory cytokines and chemokines which induce cell damage and disruption of BBB ([@b212-co-2-879]). ROS have been reported to be cytotoxic to RGCs ([@b204-co-2-879]) causing necrotic cell death by direct oxidative damage to cellular constituents and apoptotic death by participating in the signal transduction pathway for apoptosis ([@b120-co-2-879]; [@b128-co-2-879]; [@b132-co-2-879], [@b131-co-2-879]; [@b164-co-2-879]).

NO, a free radical is produced by the endothelial cells and serves as a vasodilator ([@b69-co-2-879]; [@b126-co-2-879]; [@b194-co-2-879]; [@b92-co-2-879]). However, NO, as mentioned above, can also be neurotoxic causing neuronal death in hypoxic and excitotoxic insults ([@b53-co-2-879]; [@b157-co-2-879]; [@b18-co-2-879]; [@b127-co-2-879]). It has been shown that NO can react with the superoxide anion (O~2~^−^) to form peroxynitrite (OONO^−^) ([@b12-co-2-879]) which is neurotoxic ([@b134-co-2-879]). NO alone, even at high levels, has been reported as nontoxic to cortical neurons, but becomes neurotoxic after its reaction with O~2~^−^ to form ONOO^−^ ([@b134-co-2-879]). *In vitro* studies have shown that formation of OONO^−^ increases the VEGF-induced permeability of retinal microvascular endothelial cells ([@b144-co-2-879]) and tissue damage through DNA damage, lipid peroxidation, and reduced cellular anti-oxidant defenses ([@b183-co-2-879]; [@b185-co-2-879]).

Hypoxia-ischemia and inflammation
=================================

Hypoxia is known to regulate expression of many genes modulating inflammation ([@b86-co-2-879]). An acute inflammatory reaction, characterized by increased expression of proinflammatory mediators ([@b201-co-2-879]; [@b20-co-2-879]), a rapid microglial/monocytic response ([@b96-co-2-879]) and gliosis ([@b32-co-2-879]), have been reported to be elicited in the brain by hypoxia-ischemia ([@b47-co-2-879]). Many cell types including injured neurons have been reported as a major source of chemokines such as monocyte chemoattractant protein (MCP-1) ([@b95-co-2-879]) whereas expression of macrophage inflammatory protein-α has been reported in monocytes and activated microglial cells ([@b47-co-2-879]) in hypoxic-ischemic brain injury. Chemokine receptors CCR2 and CCR5 have also been reported to be upregulated ([@b86-co-2-879]). Chemokine expression may play a role in leukocyte recruitment and infiltration in the inner retina, leading to RGC damage ([@b103-co-2-879]). Leukocytes are known to play a central role in post-ischemic tissue damage ([@b56-co-2-879]; [@b87-co-2-879]; [@b223-co-2-879]) by producing free radicals ([@b215-co-2-879]) and inflammatory cytokines ([@b71-co-2-879]).

Hypoxia-ischemia is known to attract macrophages to hypoxic areas through expression of MCP-1. The hypoxia-activated macrophages and microglia, the immune effector cells in the retina, release TNF-α which has been reported as a triggering factor to activate production of interleukin-8 (IL-8), VEGF, or MCP-1 in retinal vascular cells and/or glial cells adjacent to microvessels ([@b219-co-2-879]). Expression of TNF-α and cyclooxygenase-2 (COX-2) was reported recently in the ischemic retina ([@b224-co-2-879]). Several inflammatory molecules including ICAM-1, TNF-α, IL-1β, iNOS, and COX-2 released by activated inflammatory cells and glial elements play a major role in degeneration of retinal capillaries ([@b107-co-2-879]; [@b224-co-2-879]) and subsequently the RGCs.

Expression of adhesion molecules, ICAM-1 and VCAM-1, on the endothelial cells facilitating leukocyte adhesion and infiltration into the areas of damage has been reported to be induced by TNF-α ([@b216-co-2-879]; [@b88-co-2-879]; [@b147-co-2-879]). *In vitro* studies have shown that IL-1β and TNF-α induce ICAM-1 expression in endothelial cells ([@b62-co-2-879]). ICAM-1 is important for establishing adhesion of leukocytes before their movement across the endothelium into the tissue ([@b211-co-2-879]).

IL-1β and TNF-α may also be involved in transcriptional activation of the iNOS gene ([@b135-co-2-879]; [@b109-co-2-879]). Endothelial cells of brain microvessels are known to express iNOS and produce large amounts of NO under inflammatory conditions as IL-1β has an important role in iNOS expression and NO generation ([@b15-co-2-879]; [@b21-co-2-879]). Induction of IL-1 β gene expression in the vascular wall, accompanied by perivascular induction of iNOS mRNA was observed in the rat brain during systemic inflammation ([@b217-co-2-879]). Increased release of IL-1β and TNF-α in the retina in hypoxic-ischemic conditions may have a similar action.

Conclusion
==========

Retinal hypoxia results in increased release VEGF, NO, glutamate, inflammatory cytokines and ROS ([Figure 1](#f1-co-2-879){ref-type="fig"}). These processes result in RGC loss through various mechanisms such as disruption of BRB, excitotoxicity and increased accumulation of intracellular Ca^2+^. Understanding of the processes outlined in this review may provide new strategies to minimize RGC loss and possibly counteract or prevent it.
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